Mabwell (Shanghai) Bioscience
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (34)
A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer
Started: 12/29/2023
A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis
Started: 11/16/2024
A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer
Started: 9/10/2024
9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer
Started: 8/22/2024
Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid Tumors
Started: 3/20/2020
A Study of 9MW2821 Versus Chemotherapy in Participants With Previously Treated Locally Advanced or Metastatic Triple-Negative Breast Cancer
Started: 5/1/2026
9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer
Started: 8/1/2025
A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Started: 7/15/2025
9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
Started: 1/17/2025
A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic Triple-Negative Breast Cancer
Started: 7/26/2024
Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF
Started: 9/21/2020
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
Started: 8/11/2025
A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors
Started: 2/11/2026
First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors
Started: 11/12/2025
A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera
Started: 3/21/2024
A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent β-thalassemia
Started: 12/30/2024
9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer
Started: 9/27/2023
A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors
Started: 6/21/2022
An Evaluation of 9MW1911 Injection in Healthy Subjects
Started: 12/15/2021
A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects
Started: 3/20/2023
Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD).
Started: 7/6/2023
A Clinical Study of 9MW2821 Monotherapy or Combined With Other Anticancer Therapy in Advanced Solid Tumors
Started: 4/1/2025
9MW2821 Combined With Other Antitumor Drugs in Patients With Advanced Gynecological Tumors
Started: 4/15/2025
Single Ascending Dose Study of 9MW3011 in Chinese Healthy Subject
Started: 3/10/2023
Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors
Started: 8/28/2023
A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid Tumors
Started: 8/5/2022
A Clinical Study in Healthy Subjects to Evaluate 9MW1911 Injection
Started: 1/21/2022
A Clinical Study in Health Subjects to Evaluate 9MW1411 Injection
Started: 4/16/2021
Safety and Efficacy of 9MW0813 in Subjects With Diabetic Macular Edema
Started: 2/26/2021
Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW032 and Xgeva® in Healthy Adults
Started: 6/25/2019
Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW031 and Prolia® in Healthy Adults
Started: 6/2/2020